HDAC1 was involved in placental breast cancer resistance protein regulation in vitro: A preliminary study

被引：5
|
作者：
Duan, Hongyu [1 ,2 ]
Zhou, Kaiyu [1 ,2 ,3 ]
Zhang, Yi [2 ]
Yue, Peng [2 ,4 ]
Wang, Tao [1 ,2 ]
Li, Yifei [1 ,2 ]
Qiu, Dajian [2 ]
Hua, Yimin [1 ,2 ,3 ]
Wang, Chuan [1 ,2 ]
机构：
[1] Sichuan Univ, West China Univ Hosp 2, Dept Pediat Cardiol, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Univ Hosp 2, West China Inst Women & Childrens Hlth, Cardiac Dev & Early Intervent Unit, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Chil, Minist Educ, Chengdu, Sichuan, Peoples R China
[4] Sichuan Univ, West China Med Sch, Chengdu, Sichuan, Peoples R China
来源：
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 2019年 / 23卷 / 08期
基金：
中国国家自然科学基金;
关键词：
HISTONE DEACETYLASE; INHIBITOR; EXPRESSION;
D O I：
10.1111/jcmm.14414
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：5818 / 5821
页数：4
相关论文
共 50 条
  • [21] Expression of HDAC1 and RBBP4 correlate with clinicopathologic characteristics and prognosis in breast cancer
    Guo, Qingqun
    Cheng, Kai
    Wang, Xiaohong
    Li, Xiaoqiang
    Yu, Yue
    Hua, Yitong
    Yang, Zhenlin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (03): : 563 - 572
  • [22] ABCG2/breast cancer resistance protein (BCRP) is involved in regulation of ceramide levels in trophoblast
    Evseenko, Denis A.
    Paxton, James W.
    Keelan, Jeffrey A.
    PLACENTA, 2006, 27 (9-10) : A18 - A18
  • [23] HDAC1 triggers the proliferation and migration of breast cancer cells via upregulation of interleukin-8
    Tang, Zhaohui
    Ding, Sijuan
    Huang, Honglin
    Luo, Pengfei
    Qing, Bohua
    Zhang, Siyuan
    Tang, Ruoting
    BIOLOGICAL CHEMISTRY, 2017, 398 (12) : 1347 - 1356
  • [24] Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition
    You, Dahea
    Richardson, Jason R.
    Aleksunes, Lauren M.
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (06) : 459 - 480
  • [25] Nuclear Localization of the Transcriptional Regulator MIER1α Requires Interaction with HDAC1/2 in Breast Cancer Cells
    Li, Shengnan
    Paterno, Gary D.
    Gillespie, Laura L.
    PLOS ONE, 2013, 8 (12):
  • [26] PI3K/mTOR mediate mitogen-dependent HDAC1 phosphorylation in breast cancer: a novel regulation of estrogen receptor expression
    Citro, Simona
    Miccolo, Claudia
    Meloni, Laura
    Chiocca, Susanna
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2015, 7 (02) : 132 - 142
  • [27] A novel HDAC1/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulation
    Lee, Hsueh-Yun
    Tang, Di-Wei
    Liu, Chi-Yuan
    Cho, Er-Chieh
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 352
  • [28] The combination of the HDAC1 inhibitor SAHA and doxorubicin has synergic efficacy in triple negative breast cancer in vivo
    Pang, Yuheng
    Shi, Runze
    Chan, Liujia
    Lu, Yu
    Zhu, Di
    Liu, Tong
    Yan, Meisi
    Wang, Yuji
    Wang, Wenjing
    PHARMACOLOGICAL RESEARCH, 2023, 196
  • [29] Placental expression of breast cancer resistance protein (BCRP1) in the mouse: Fetal protection.
    Kalabis, GM
    Morassaei, S
    Petropoulos, S
    Gibb, W
    Mattliews, SG
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2006, 13 (02) : 320A - 320A
  • [30] Regulation of Nur77 protein turnover through acetylation and deacetylation induced by p300 and HDAC1
    Kang, Shin-Ae
    Na, Hyelin
    Kang, Hyun-Jin
    Kim, Sung-Hye
    Lee, Min-Ho
    Lee, Mi-Ock
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (06) : 867 - 873
12345